1 Table of Contents
1.1 List of Tables
List of Figures

2 Executive Summary
2.1 Narcolepsy- Disease Overview
2.2 Narcolepsy- Pipeline Snapshot
2.3 Narcolepsy- Pipeline Drugs by Phase
2.4 Narcolepsy- Pipeline Drugs by Company
2.5 Narcolepsy- Pipeline Drugs by Mechanism of Action

3 Company wise Pipeline Analysis
3.1 Avadel Pharmaceuticals Plc Narcolepsy Drug Pipeline, H2- 2019
3.2 Axsome Therapeutics Inc Narcolepsy Drug Pipeline, H2- 2019
3.3 Balance Therapeutics Inc Narcolepsy Drug Pipeline, H2- 2019
3.4 Bioprojet SCR Narcolepsy Drug Pipeline, H2- 2019
3.5 Evotec AG Narcolepsy Drug Pipeline, H2- 2019
3.6 F. Hoffmann-La Roche Ltd Narcolepsy Drug Pipeline, H2- 2019
3.7 H.A.C. Pharma Narcolepsy Drug Pipeline, H2- 2019
3.8 Jazz Pharmaceuticals Plc Narcolepsy Drug Pipeline, H2- 2019
3.9 NLS Pharmaceutics Ltd Narcolepsy Drug Pipeline, H2- 2019
3.10 Ono Pharmaceutical Co Ltd Narcolepsy Drug Pipeline, H2- 2019
3.11 OptiNose US Inc Narcolepsy Drug Pipeline, H2- 2019
3.12 Seelos Therapeutics Inc Narcolepsy Drug Pipeline, H2- 2019
3.13 SK Biopharmaceuticals Co Ltd Narcolepsy Drug Pipeline, H2- 2019
3.14 Sosei Heptares Narcolepsy Drug Pipeline, H2- 2019
3.15 SRI International Narcolepsy Drug Pipeline, H2- 2019
3.16 Suven Neurosciences Inc Narcolepsy Drug Pipeline, H2- 2019
3.17 Taisho Pharmaceutical Holdings Co Ltd Narcolepsy Drug Pipeline, H2- 2019
3.18 Takeda Pharmaceutical Co Ltd Narcolepsy Drug Pipeline, H2- 2019
3.19 Theranexus SAS Narcolepsy Drug Pipeline, H2- 2019
3.20 XW Laboratories Inc Narcolepsy Drug Pipeline, H2- 2019

4 Phase 1 Pipeline Drug Details
4.1 Narcolepsy- Phase 1 Drug Details
4.2 Narcolepsy- Phase 1 Drug Overview
4.3 Narcolepsy- Phase 1 Mechanism of Action
4.4 Current Status
4.5 Trial Details

5 Phase 2 Pipeline Drug Details
5.1 Narcolepsy- Phase 2 Drug Details
5.2 Narcolepsy- Phase 2 Drug Overview
5.3 Narcolepsy- Phase 2 Mechanism of Action
5.4 Current Status
5.5 Trial Details

6 Phase 3 Pipeline Drug Details
6.1 Narcolepsy- Phase 3 Drug Details
6.2 Narcolepsy- Phase 3 Drug Overview
6.3 Narcolepsy- Phase 3 Drug Mechanism of Action
6.4 Current Status
6.5 Trial Details

7 Pre-clinical Phase Pipeline Drug Details
7.1 Narcolepsy- Pre-clinical Phase Drug Details
7.2 Narcolepsy- Pre-clinical Phase Drug Overview
7.3 Narcolepsy- Pre-clinical Phase Drug Mechanism of Action
7.4 Current Status
7.5 Trial Details

8 Recent News and Developments

9 Appendix
9.1 About VPAResearch
9.2 Sources and Research Methodology

Companies mentioned
Avadel Pharmaceuticals Plc, Axsome Therapeutics Inc, Balance Therapeutics Inc, Bioprojet SCR, Evotec AG, F. Hoffmann-La Roche Ltd, H.A.C. Pharma, Jazz Pharmaceuticals Plc, NLS Pharmaceutics Ltd, Ono Pharmaceutical Co Ltd, OptiNose US Inc, Seelos Therapeutics Inc, SK Biopharmaceuticals Co Ltd, Sosei Heptares, SRI International, Suven Neurosciences Inc , Taisho Pharmaceutical Holdings Co Ltd, Takeda Pharmaceutical Co Ltd, Theranexus SAS, XW Laboratories Inc